Search results
Results from the WOW.Com Content Network
AMGen corporate logo, 1983 Argentine president Mauricio Macri meets with heads of Amgen, in 2018. Amgen was established in Thousand Oaks in 1980, as Applied Molecular Genetics. [6] [7] Amgen was backed by a small group of venture capitalists, and its early focus was on recombinant DNA technology and recombinant human insulin. [8]
Before you buy stock in Amgen, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Amgen wasn’t one ...
The so-called boxed warning, issued on Friday, comes after the health regulator in 2022 started a review into the risk of very low blood calcium in patients with advanced chronic kidney disease ...
3 Largest selling pharmaceutical products of 2015. 4 Best selling pharmaceuticals of 2013. 5 See also. 6 References. ... Amgen: Rheumatoid arthritis: Nov-1998: 2012 ...
Amgen added Uplizna via a $27.8 billion acquisition of Horizon Therapeutics and recorded sales of $80 million in the first quarter of 2024. The trial met its primary endpoint, showing a ...
Shares of Amgen, which fell by less than 1% to close at $314.72 on Nasdaq, were unchanged after hours. (Reporting By Deena Beasley and Sneha S K; Editing by Bill Berkrot, Shailesh Kuber and Jamie ...
Amgen has not seen an association, but the current study is tracking that, Honarpour said. "Obesity is the disease that causes all of the others," Apovian said. "We need a wide array of options."
In 2019, Amgen Inc. acquired 20.5% of BeiGene in a deal valued at $2.7 billion, and gained a seat on BeiGene's board of directors. In turn, BeiGene acquired the rights to commercialize three Amgen pharmaceuticals, Xgeva, Kyprolis, and Blincyto, as well as 20 others in development, investing up to $1.25 billion toward their research. [44]